Cargando…
Differential Diagnosis of Type 1 and Type 2 Papillary Renal Cell Carcinoma Based on Enhanced CT Radiomics Nomogram
OBJECTIVES: To construct a contrast-enhanced CT-based radiomics nomogram that combines clinical factors and a radiomics signature to distinguish papillary renal cell carcinoma (pRCC) type 1 from pRCC type 2 tumours. METHODS: A total of 131 patients with 60 in pRCC type 1 and 71 in pRCC type 2 were e...
Autores principales: | Gao, Yankun, Wang, Xingwei, Wang, Shihui, Miao, Yingying, Zhu, Chao, Li, Cuiping, Huang, Guoquan, Jiang, Yan, Li, Jianying, Zhao, Xiaoying, Wu, Xingwang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204229/ https://www.ncbi.nlm.nih.gov/pubmed/35719928 http://dx.doi.org/10.3389/fonc.2022.854979 |
Ejemplares similares
-
Development and validation of a clinical radiomics nomogram to predict secondary loss of response to infliximab in Crohn's disease patients
por: Zhu, Chao, et al.
Publicado: (2023) -
Multiphase CT radiomics nomogram for preoperatively predicting the WHO/ISUP nuclear grade of small (< 4 cm) clear cell renal cell carcinoma
por: Gao, Yankun, et al.
Publicado: (2023) -
A Clinical Radiomics Nomogram Was Developed by Integrating Radiomics Signatures and Clinical Variables to Distinguish High-Grade ccRCC from Type 2 pRCC
por: Gao, Yankun, et al.
Publicado: (2022) -
Erratum to “Development and validation of a clinical radiomics nomogram to predict secondary loss of response to infliximab in Crohn’s disease patients” [Heliyon 9(4) (April 2023) e14594]
por: Zhu, Chao, et al.
Publicado: (2023) -
A Novel Clinical Radiomics Nomogram to Identify Crohn’s Disease from Intestinal Tuberculosis
por: Zhu, Chao, et al.
Publicado: (2021)